259 related articles for article (PubMed ID: 19808979)
1. Triptolide is an inhibitor of RNA polymerase I and II-dependent transcription leading predominantly to down-regulation of short-lived mRNA.
Vispé S; DeVries L; Créancier L; Besse J; Bréand S; Hobson DJ; Svejstrup JQ; Annereau JP; Cussac D; Dumontet C; Guilbaud N; Barret JM; Bailly C
Mol Cancer Ther; 2009 Oct; 8(10):2780-90. PubMed ID: 19808979
[TBL] [Abstract][Full Text] [Related]
2. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
[TBL] [Abstract][Full Text] [Related]
3. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and computational evaluation of Triptolide-induced cytotoxicity against NSCLC.
Hamdi AM; Jiang ZZ; Guerram M; Yousef BA; Hassan HM; Ling JW; Zhang LY
Biomed Pharmacother; 2018 Jul; 103():1557-1566. PubMed ID: 29864943
[TBL] [Abstract][Full Text] [Related]
5. Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44.
Yi JM; Huan XJ; Song SS; Zhou H; Wang YQ; Miao ZH
Mol Cancer Ther; 2016 Jul; 15(7):1495-503. PubMed ID: 27197304
[TBL] [Abstract][Full Text] [Related]
6. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of RNA polymerase III transcription by Triptolide attenuates colorectal tumorigenesis.
Liang X; Xie R; Su J; Ye B; Wei S; Liang Z; Bai R; Chen Z; Li Z; Gao X
J Exp Clin Cancer Res; 2019 May; 38(1):217. PubMed ID: 31122284
[TBL] [Abstract][Full Text] [Related]
8. NF-κB signaling inhibition and anticancer activities of LLDT-246 on human colorectal cancer HCT-116 cells in vitro.
Li M; Wang X; Liu M; Qi X; Li J
Biomed Pharmacother; 2014 Jun; 68(5):527-35. PubMed ID: 24986326
[TBL] [Abstract][Full Text] [Related]
9. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
[TBL] [Abstract][Full Text] [Related]
10. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
11. Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1.
Nakazato T; Sagawa M; Kizaki M
Int J Oncol; 2014 Apr; 44(4):1131-8. PubMed ID: 24481531
[TBL] [Abstract][Full Text] [Related]
12. Triptolide (TPL) inhibits global transcription by inducing proteasome-dependent degradation of RNA polymerase II (Pol II).
Wang Y; Lu JJ; He L; Yu Q
PLoS One; 2011; 6(9):e23993. PubMed ID: 21931633
[TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.
Johnson SM; Wang X; Evers BM
J Surg Res; 2011 Jun; 168(2):197-205. PubMed ID: 19922946
[TBL] [Abstract][Full Text] [Related]
14. Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.
Li R; Zhang Z; Wang J; Huang Y; Sun W; Xie R; Hu F; Lei T
Biomed Pharmacother; 2017 Nov; 95():771-779. PubMed ID: 28892788
[TBL] [Abstract][Full Text] [Related]
15. Triptolide interferes with XRCC1/PARP1-mediated DNA repair and confers sensitization of triple-negative breast cancer cells to cisplatin.
Zhang Z; Sun C; Zhang L; Chi X; Ji J; Gao X; Wang Y; Zhao Z; Liu L; Cao X; Yang Y; Mao W
Biomed Pharmacother; 2019 Jan; 109():1541-1546. PubMed ID: 30551406
[TBL] [Abstract][Full Text] [Related]
16. Triptolide blocks the STAT3 signaling pathway through induction of protein tyrosine phosphatase SHP-1 in multiple myeloma cells.
Kim JH; Park B
Int J Mol Med; 2017 Nov; 40(5):1566-1572. PubMed ID: 28901387
[TBL] [Abstract][Full Text] [Related]
17. Triptolide inhibits B7-H1 expression on proinflammatory factor activated renal tubular epithelial cells by decreasing NF-kappaB transcription.
Chen Y; Zhang J; Li J; Zhao T; Zou L; Tang Y; Zhang X; Wu Y
Mol Immunol; 2006 Mar; 43(8):1088-98. PubMed ID: 16129490
[TBL] [Abstract][Full Text] [Related]
18. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
19. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway.
Huang M; Zhang H; Liu T; Tian D; Gu L; Zhou M
Mol Cancer Ther; 2013 Feb; 12(2):184-94. PubMed ID: 23243057
[TBL] [Abstract][Full Text] [Related]
20. Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes.
Chueh FS; Chen YL; Hsu SC; Yang JS; Hsueh SC; Ji BC; Lu HF; Chung JG
Oncol Rep; 2013 Feb; 29(2):613-8. PubMed ID: 23233170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]